I-Retagliptin
Iinkcukacha zeMveliso
Iithegi zeMveliso
Ubungakanani bePakethi | Ubukho | Ixabiso (USD) |
Igama leMchiza:
(R) -methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine- I-1-carboxylate phosphate
Ikhowudi yoncumo:
COC(C1=NC([N]2=C1CN(C(C[C@@H](CC3=C(F)C=C(F)C(F)=C3)N)=O)CC2)C (F)(F)F)=O
Ikhowudi ye-InChi:
InChI=1S/C19H19F6N4O3/c1-32-17(31)16-14-8-28(2-3-29(14)18(27-16)19(23,24)25)15(30)6- 10(26)4-9-5-12(21)13(22)7-11(9)20/h5,7,10,18H,2-4,6,8,26H2,1H3/t10-,18 ?/m1/s1
Isitshixo se-InChi:
FXBCTRLEFVUDDC-DMPGVRBJSA-N
Igama elingundoqo:
I-Retagliptin, SP-2086,SP2086,1174122-54-3, 1256756-88-3
Ukunyibilika:Inyibilika kwi-DMSO
Ugcino:0 - 4°C ixesha elifutshane (iintsuku ukuya kwiiveki), okanye -20°C ixesha elide (iinyanga).
Inkcazo:
I-Retagliptin, ekwabizwa ngokuba yi-SP-2086, yi-DPP-4 inhibitor enokuthi isetyenziswe kunyango lwe-Type 2 yeswekile.
Ithagethi: DPP-4